JANX: Janux Therapeutics Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Janux Therapeutics Inc (JANX).

OverviewDividends

$2.81B Market Cap.

As of 05/09/2025 5:00 PM ET (MRY) • Disclaimer

JANX Market Cap. (MRY)


JANX Shares Outstanding (MRY)


JANX Assets (MRY)


Total Assets

$1.06B

Total Liabilities

$38.73M

Total Investments

$594.57M

JANX Income (MRY)


Revenue

$10.59M

Net Income

-$68.99M

Operating Expense

$109.44M

JANX Cash Flow (MRY)


CF Operations

-$43.81M

CF Investing

-$258.02M

CF Financing

$713.24M

JANX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$1,061,516,000 (179.05%)

$380,407,000 (4.50%)

$364,010,000 (-4.16%)

$379,824,000 (2242.13%)

Assets Current

$1,033,666,000 (195.97%)

$349,241,000 (5.05%)

$332,439,000 (-11.82%)

$377,019,000 (2247.27%)

Assets Non-Current

$27,850,000 (-10.64%)

$31,166,000 (-1.28%)

$31,571,000 (1025.53%)

$2,805,000 (1709.68%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$1,022,781,000 (197.02%)

$344,349,000 (7.36%)

$320,740,000 (-12.44%)

$366,327,000 (2602.58%)

Property Plant & Equipment Net

$24,150,000 (-13.26%)

$27,841,000 (-5.19%)

$29,365,000 (1738.76%)

$1,597,000 (930.32%)

Cash & Equivalents

$431,421,000 (2054.84%)

$20,021,000 (-61.68%)

$52,242,000 (43.53%)

$36,398,000 (365.86%)

Accumulated Other Comprehensive Income

$2,163,000 (225.26%)

$665,000 (143.32%)

-$1,535,000 (-468.52%)

-$270,000 (0%)

Deferred Revenue

$0 (0%)

$1,705,000 (-77.65%)

$7,627,000 (30.09%)

$5,863,000 (-26.71%)

Total Investments

$594,568,000 (83.04%)

$324,823,000 (17.86%)

$275,590,000 (-18.80%)

$339,383,000 (0%)

Investments Current

$594,568,000 (83.04%)

$324,823,000 (17.86%)

$275,590,000 (-18.80%)

$339,383,000 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$4,026,000 (66.09%)

$2,424,000 (12.27%)

$2,159,000 (-12.16%)

$2,458,000 (474.30%)

Accumulated Retained Earnings (Deficit)

-$237,757,000 (-40.88%)

-$168,763,000 (-52.77%)

-$110,470,000 (-133.00%)

-$47,411,000 (-221.67%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$23,025,000 (-6.18%)

$24,542,000 (-3.02%)

$25,305,000 (12943.81%)

$194,000 (0%)

Debt Current

$1,749,000 (15.29%)

$1,517,000 (98.82%)

$763,000 (293.30%)

$194,000 (0%)

Debt Non-Current

$21,276,000 (-7.60%)

$23,025,000 (-6.18%)

$24,542,000 (0%)

$0 (0%)

Total Liabilities

$38,735,000 (7.42%)

$36,058,000 (-16.67%)

$43,270,000 (220.59%)

$13,497,000 (46.21%)

Liabilities Current

$17,459,000 (33.96%)

$13,033,000 (-21.05%)

$16,507,000 (28.99%)

$12,797,000 (302.29%)

Liabilities Non-Current

$21,276,000 (-7.60%)

$23,025,000 (-13.97%)

$26,763,000 (3723.29%)

$700,000 (-88.43%)

JANX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$10,588,000 (30.99%)

$8,083,000 (-6.14%)

$8,612,000 (136.79%)

$3,637,000 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$41,047,000 (57.03%)

$26,140,000 (17.42%)

$22,262,000 (115.53%)

$10,329,000 (473.20%)

Research & Development Expense

$68,388,000 (24.52%)

$54,922,000 (2.77%)

$53,441,000 (103.69%)

$26,237,000 (762.78%)

Operating Expenses

$109,435,000 (35.00%)

$81,062,000 (7.08%)

$75,703,000 (107.03%)

$36,566,000 (655.03%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$68,994,000 (-18.36%)

-$58,293,000 (7.56%)

-$63,059,000 (-93.01%)

-$32,672,000 (-381.60%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$68,994,000 (-18.36%)

-$58,293,000 (7.56%)

-$63,059,000 (-93.01%)

-$32,672,000 (-381.60%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$68,994,000 (-18.36%)

-$58,293,000 (7.56%)

-$63,059,000 (-93.01%)

-$32,672,000 (-381.60%)

Weighted Average Shares

$53,751,480 (22.12%)

$44,016,283 (6.14%)

$41,469,631 (76.24%)

$23,530,252 (2471.20%)

Weighted Average Shares Diluted

$53,751,480 (22.12%)

$44,016,283 (6.14%)

$41,469,631 (76.24%)

$23,530,252 (2471.20%)

Earning Before Interest & Taxes (EBIT)

-$68,994,000 (-18.36%)

-$58,293,000 (7.56%)

-$63,059,000 (-93.01%)

-$32,672,000 (-396.69%)

Gross Profit

$10,588,000 (30.99%)

$8,083,000 (-6.14%)

$8,612,000 (136.79%)

$3,637,000 (0%)

Operating Income

-$98,847,000 (-35.45%)

-$72,979,000 (-8.78%)

-$67,091,000 (-103.74%)

-$32,929,000 (-579.93%)

JANX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$258,021,000 (-526.36%)

-$41,194,000 (-170.70%)

$58,266,000 (117.09%)

-$340,963,000 (0%)

Net Cash Flow from Financing

$713,235,000 (1097.75%)

$59,548,000 (11809.60%)

$500,000 (-99.87%)

$386,524,000 (3254.08%)

Net Cash Flow from Operations

-$43,814,000 (13.37%)

-$50,575,000 (-17.83%)

-$42,922,000 (-152.84%)

-$16,976,000 (-288.56%)

Net Cash Flow / Change in Cash & Cash Equivalents

$411,400,000 (1376.81%)

-$32,221,000 (-303.36%)

$15,844,000 (-44.57%)

$28,585,000 (299.51%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$257,662,000 (-554.90%)

-$39,344,000 (-160.80%)

$64,711,000 (119.06%)

-$339,481,000 (0%)

Capital Expenditure

-$359,000 (80.59%)

-$1,850,000 (71.30%)

-$6,445,000 (-334.89%)

-$1,482,000 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$713,235,000 (1097.75%)

$59,548,000 (11809.60%)

$500,000 (-99.76%)

$205,977,000 (294152.86%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$33,020,000 (65.06%)

$20,005,000 (16.29%)

$17,203,000 (148.96%)

$6,910,000 (9497.22%)

Depreciation Amortization & Accretion

$2,060,000 (5.37%)

$1,955,000 (132.46%)

$841,000 (644.25%)

$113,000 (769.23%)

JANX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00%

Profit Margin

-651.60% (9.65%)

-721.20% (1.50%)

-732.20% (18.49%)

-898.30%

EBITDA Margin

-632.20% (9.30%)

-697.00% (3.53%)

-722.50% (19.29%)

-895.20%

Return on Average Equity (ROAE)

-9.20% (48.60%)

-17.90% (4.28%)

-18.70% (-58.47%)

-11.80% (-119.63%)

Return on Average Assets (ROAA)

-8.80% (45.00%)

-16.00% (5.33%)

-16.90% (-60.95%)

-10.50% (86.92%)

Return on Sales (ROS)

-651.60% (9.65%)

-721.20% (1.50%)

-732.20% (18.49%)

-898.30%

Return on Invested Capital (ROIC)

-11.10% (33.53%)

-16.70% (15.66%)

-19.80% (-21.47%)

-16.30% (94.28%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-41.83 (-414.55%)

-8.13 (6.17%)

-8.66 (38.96%)

-14.19

Price to Sales Ratio (P/S)

271.8 (365.17%)

58.43 (-7.86%)

63.42 (-50.32%)

127.65

Price to Book Ratio (P/B)

2.75 (90.90%)

1.44 (-15.90%)

1.71 (-23.65%)

2.24

Debt to Equity Ratio (D/E)

0.04 (-63.81%)

0.1 (-22.22%)

0.14 (264.86%)

0.04 (105.86%)

Earnings Per Share (EPS)

-1.28 (3.03%)

-1.32 (13.16%)

-1.52 (-9.35%)

-1.39 (81.24%)

Sales Per Share (SPS)

0.2 (7.07%)

0.18 (-11.54%)

0.21 (34.19%)

0.15 (0%)

Free Cash Flow Per Share (FCFPS)

-0.82 (30.98%)

-1.19 (-0.08%)

-1.19 (-51.79%)

-0.78 (83.58%)

Book Value Per Share (BVPS)

19.03 (143.23%)

7.82 (1.15%)

7.73 (-50.32%)

15.57 (197.33%)

Tangible Assets Book Value Per Share (TABVPS)

19.75 (128.52%)

8.64 (-1.55%)

8.78 (-45.62%)

16.14 (-8.91%)

Enterprise Value Over EBIT (EV/EBIT)

-41 (-355.56%)

-9 (-12.50%)

-8 (66.67%)

-24

Enterprise Value Over EBITDA (EV/EBITDA)

-41.92 (-370.14%)

-8.92 (-9.37%)

-8.15 (66.05%)

-24.01

Asset Turnover

0.01 (-36.36%)

0.02 (-4.35%)

0.02 (91.67%)

0.01 (0%)

Current Ratio

59.2 (120.94%)

26.8 (33.06%)

20.14 (-31.64%)

29.46 (483.52%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$44,173,000 (15.74%)

-$52,425,000 (-6.19%)

-$49,367,000 (-167.46%)

-$18,458,000 (-322.48%)

Enterprise Value (EV)

$2,805,748,351 (458.57%)

$502,312,254 (-0.97%)

$507,226,092 (-35.12%)

$781,841,092

Earnings Before Tax (EBT)

-$68,994,000 (-18.36%)

-$58,293,000 (7.56%)

-$63,059,000 (-93.01%)

-$32,672,000 (-381.60%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$66,934,000 (-18.81%)

-$56,338,000 (9.45%)

-$62,218,000 (-91.09%)

-$32,559,000 (-395.95%)

Invested Capital

$635,661,000 (70.92%)

$371,895,000 (16.01%)

$320,566,000 (-3.10%)

$330,823,000 (6233.97%)

Working Capital

$1,016,207,000 (202.26%)

$336,208,000 (6.42%)

$315,932,000 (-13.26%)

$364,222,000 (2727.59%)

Tangible Asset Value

$1,061,516,000 (179.05%)

$380,407,000 (4.50%)

$364,010,000 (-4.16%)

$379,824,000 (2242.13%)

Market Capitalization

$2,809,887,351 (467.21%)

$495,387,254 (-9.72%)

$548,702,092 (-33.17%)

$820,995,092

Average Equity

$748,081,250 (129.47%)

$326,007,500 (-3.56%)

$338,037,250 (21.69%)

$277,775,250 (2560.15%)

Average Assets

$784,232,750 (114.61%)

$365,428,250 (-2.14%)

$373,432,000 (20.51%)

$309,887,500 (3568.18%)

Invested Capital Average

$621,629,500 (78.03%)

$349,178,750 (9.52%)

$318,827,250 (59.33%)

$200,107,750 (8568.30%)

Shares

52,482,020 (13.68%)

46,168,430 (10.81%)

41,663,029 (0.12%)

41,611,510